Post Subject #117   EOLS 4Q19 estimated sales=$18.5-19.5M—including $0.7M ex-US: DewDiligence 01/09/20 11:24:52 AM #120   Alphaeon 1 LLC owned 25.9% of EOLS (8.67M DewDiligence 01/17/20 05:36:34 PM #119   Alphaeon changes name to Aeon Biosciences and spins DewDiligence 01/10/20 06:55:14 PM #118   EOLS new corporate slide set: DewDiligence 01/10/20 11:50:02 AM #117   EOLS 4Q19 estimated sales=$18.5-19.5M—including $0.7M ex-US: DewDiligence 01/09/20 11:24:52 AM #116   EOLS’ CMO sold ~40% of stockholding (~$500K) yesterday: DewDiligence 01/08/20 07:47:05 PM #115   EOLS -9% today; their investors presumably think RVNC’s DewDiligence 12/04/19 12:01:11 PM #114   EOLS sells 6.0M* shares @$13.00—a 16% discount to DewDiligence 11/07/19 10:13:31 AM #113   I thought they had cash reserves for 12 enthalpy 11/06/19 06:12:12 PM #112   damn then they are losing more money. I enthalpy 11/06/19 05:37:56 PM #111   I hope it's for other revenue purposes... What DewDiligence 11/06/19 05:02:22 PM #110   well I guess we will be okay. I enthalpy 11/06/19 04:59:55 PM #109   The CFO actually promised this was coming: DewDiligence 11/06/19 04:50:59 PM #108   scumbags cant make it. unspecified dilution probably means enthalpy 11/06/19 04:46:26 PM #107   EOLS raising unspecified amount in underwritten offering: DewDiligence 11/06/19 04:07:59 PM #106   EOLS 3Q19 results—Jeuveau sales=$13.2M: DewDiligence 11/04/19 08:23:57 AM #105   From the same source:With the shipments of Nabota DewDiligence 10/22/19 07:50:57 AM #104   http://m.koreabiomed.com/news/articleView.html?idxno=6634 enthalpy 10/22/19 07:28:59 AM #103   EU approves Nuceiva* for glabellar lines: DewDiligence 10/01/19 09:46:36 AM #102   gap is filled up we go enthalpy 09/04/19 12:08:38 PM #101   Well good luck waiting on rvnc. Me too Ortho91 08/30/19 04:10:58 PM #100   The test wasn’t conducted by Daewoong. It was Ortho91 08/30/19 04:09:35 PM #99   RVNC will be great but stop with your DewDiligence 08/30/19 04:07:53 PM #98   Medytox points to the upcoming ITC analysis of DewDiligence 08/30/19 04:06:58 PM #97   Sure okay. Differing opinion but I also get Ortho91 08/30/19 04:01:24 PM #96   Korean article on Daewoong spores: DewDiligence 08/30/19 03:55:10 PM #95   Daewoong strain produces spores. Bad news for Medytox. Ortho91 08/29/19 09:56:36 PM #94   Cramer's show is the ideal venue for EOLS, LOL. DewDiligence 08/12/19 07:15:10 PM #93   So many traps and the CEO on the kris_kade 08/12/19 07:03:15 PM #92   EOLS 2Q19 CC transcript: DewDiligence 08/12/19 03:40:26 PM #91   2Q19 Jeuveau sales=$2.3M: DewDiligence 08/12/19 12:08:45 PM #89   EOLS AMG 08/07/19 10:46:41 PM #88   According to a source in that aricle, Daewoong DewDiligence 08/07/19 11:40:02 AM #87   looks promising https://www.fiercepharma.com/marketing/botox-growth-makes-a-ca enthalpy 08/06/19 07:22:25 PM #86   EOLS’ marketing approval in EU delayed for unspecified reason: DewDiligence 06/10/19 10:29:18 AM #85   Makes for a good trade though. Love JohnConnor67 06/07/19 01:50:34 PM #84   I agree with your assessment.... 220v 06/07/19 11:10:39 AM #83   Lots of Serious Side Effects that are labeled 220v 06/07/19 11:08:37 AM #82   Its just a trade. Low float, manipulated. JohnConnor67 06/05/19 05:55:31 PM #81   CFO just said on Jefferies webcast that EOLS DewDiligence 06/05/19 04:56:11 PM #80   So you admit they have huge capital expenditure JohnConnor67 06/05/19 03:47:52 PM #79   ...no shit its a startup. If you decided DewDiligence 06/05/19 03:43:48 PM #78   Well no shit its a startup. If JohnConnor67 06/05/19 03:32:40 PM #77   EOLS doesn't expect to be profitable this year. DewDiligence 06/05/19 03:02:42 PM #76   We picked $EOLS @ $13.60 for our short JohnConnor67 06/05/19 02:57:57 PM #75   Alphaeon completes sale of 5.3M EOLS shares: 4.0M DewDiligence 05/22/19 07:42:58 PM #74   EOLS’ share count just increased by 1.3M: DewDiligence 05/21/19 10:15:06 AM #73   Overreaction and bounce imminent imo.. faxedreceipts 05/16/19 03:24:16 PM #72   a nice down day today. diluted ownership. enthalpy 05/16/19 09:02:41 AM #71   EOLS files prospectus for 4M-share secondary offering by Alphaeon: DewDiligence 05/15/19 05:23:30 PM #70   EOLS finally launches Jeuveau (3.5 months post-FDA-approval): DewDiligence 05/15/19 09:38:30 AM Post Subject

© 2020 InvestorsHub.com, Inc.